Author:
Higuchi Kohei,Sawada Akihisa,Kondo Osamu,Okada Yosuke,Tsujimoto Hiroshi,Ioi Aya,Mayumi Azusa,Shimizu Mariko,Sato Maho,Goto Kimitoshi,Inoue Shota,Yasui Masahiro,Inoue Masami
Publisher
Springer Science and Business Media LLC
Reference22 articles.
1. Hunger SP, Loh ML, Whitlock JA, Winick NJ, Carroll WL, Devidas M, et al. COG Acute Lymphoblastic Leukemia Committee. Children’s Oncology Group’s 2013 blueprint for research: acute lymphoblastic leukemia. Pediatr Blood Cancer. 2013;60(6):957–63.
2. Schrappe M, Möricke A, Reiter A, Henze G, Welte K, Gadner H, et al. Key treatment questions in childhood acute lymphoblastic leukemia: results in 5 consecutive trials performed by the ALL-BFM study group from 1981 to 2000. Klin Padiatr. 2013;225(Suppl 1):S62-72.
3. Kato M, Manabe A. Treatment and biology of pediatric acute lymphoblastic leukemia. Pediatr Int. 2018;60(1):4–12.
4. Gamis AS, Alonzo TA, Perentesis JP, Meshinchi S. COG Acute Myeloid Leukemia Committee. Children’s Oncology Group’s 2013 blueprint for research: acute myeloid leukemia. Pediatr Blood Cancer. 2013;60(6):964–71.
5. Aversa F, Terenzi A, Tabilio A, Falzetti F, Carotti A, Ballanti S, et al. Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. J Clin Oncol. 2005;23:3447–54.